Hip fractures: a worldwide problem today and tomorrow
- PMID: 8110512
- DOI: 10.1016/8756-3282(93)90341-7
Hip fractures: a worldwide problem today and tomorrow
Abstract
Hip fractures lead to excess deaths and substantial disability. Most are related both to falls and to osteoporosis, which affects one in four post-menopausal white women, but a lesser number of men or women of other races. Consequently, about half of the 1.66 million hip fractures worldwide in 1990 occurred in Europe and North America. Even within these regions, however, there is substantial variation in hip fracture incidence rates, which suggests the existence of important environmental factors that could be manipulated to reduce hip fracture occurrence. This is important because in the United States alone, a quarter of a million hip fractures annually cost over $8 billion, mostly for acute medical care and nursing home services. Future costs will be even greater because populations are ageing rapidly around the world and because hip fracture incidence rates are rising in some regions. The number of elderly is increasing most rapidly in Asia, Latin America, the Middle East, and Africa, and these regions will account for over 70% of the 6.26 million hip fractures expected in the year 2050. Because fracture treatment is expensive, and rehabilitation not always successful, effective prophylaxis offers the only hope of alleviating the enormous social burden of hip fractures.
Similar articles
-
Epidemiology of hip fractures.Bone. 1996 Jan;18(1 Suppl):57S-63S. doi: 10.1016/8756-3282(95)00381-9. Bone. 1996. PMID: 8717549 Review.
-
Epidemiology of hip fractures: implications of the exponential increase with age.Bone. 1996 Mar;18(3 Suppl):121S-125S. doi: 10.1016/8756-3282(95)00492-0. Bone. 1996. PMID: 8777076 Review.
-
Costs and health effects of osteoporotic fractures.Bone. 1994 Jul-Aug;15(4):377-86. doi: 10.1016/8756-3282(94)90813-3. Bone. 1994. PMID: 7917575
-
Health-economic comparison of three recommended drugs for the treatment of osteoporosis.Int J Clin Pharmacol Res. 2004;24(1):1-10. Int J Clin Pharmacol Res. 2004. PMID: 15575171
-
Hip fractures in the elderly: a world-wide projection.Osteoporos Int. 1992 Nov;2(6):285-9. doi: 10.1007/BF01623184. Osteoporos Int. 1992. PMID: 1421796
Cited by
-
Regional anesthesia as compared with general anesthesia for surgery in geriatric patients with hip fracture: does it decrease morbidity, mortality, and health care costs? Results of a single-centered study.Pain Med. 2012 Jul;13(7):948-56. doi: 10.1111/j.1526-4637.2012.01402.x. Epub 2012 Jul 3. Pain Med. 2012. PMID: 22758782 Free PMC article.
-
Risk factors for hip fractures in a middle-aged population: a study of 33,000 men and women.Osteoporos Int. 2005 Dec;16(12):2185-94. doi: 10.1007/s00198-005-2006-1. Epub 2005 Sep 22. Osteoporos Int. 2005. PMID: 16177836
-
Increase in pore area, and not pore density, is the main determinant in the development of porosity in human cortical bone.J Anat. 2006 Aug;209(2):219-30. doi: 10.1111/j.1469-7580.2006.00589.x. J Anat. 2006. PMID: 16879600 Free PMC article.
-
Incidence of hip fracture in the Republic of Ireland and future projections: a population-based study.Osteoporos Int. 2009 Dec;20(12):2105-10. doi: 10.1007/s00198-009-0922-1. Epub 2009 Apr 1. Osteoporos Int. 2009. PMID: 19337676
-
Osteogenic Potential of a Biomaterial Enriched with Osteostatin and Mesenchymal Stem Cells in Osteoporotic Rabbits.Biomolecules. 2024 Jan 23;14(2):143. doi: 10.3390/biom14020143. Biomolecules. 2024. PMID: 38397380 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical